Sharps Compliance — Investor Presentation (January 2012)
31 slides from Sharps Compliance's investor presentation, Jan 24, 2012
Slide 1: Investor Presentation January 2012
David P. Tusa Chief Executive Officer and President Diana P. Diaz Vice President and Chief Financial Officer NASDAQ: SMED JANUARY 2012 Investor Presentation
Slide 2: Safe Harbor Statement
Safe Harbor Statement These slides contain (and the accompanying oral discussion will contain) “ forward-looking statements ” within the meaning of the Private Securities Litigation Reform Act of 1995. The words “ believe ” , “ estimate ” , “ anticipate ” , “ project ” and “ expect ” and similar exp
Slide 3: Sharps Compliance
Sharps Compliance NASDAQ: SMED Market capitalization $54.4 million Recent price $3.61 52-week range $5.79 - $2.66 Avg. daily trading volume 40,434 (3 mos.) Market data as of January 20, 2012, ownership as of most recent filing Fiscal Year-End June 30 th Total shares outstanding 15.1 million Ownershi
Slide 4: Capitalizing on Major National Challenges
Capitalizing on Major National Challenges
Slide 5: Growing Volume of Medical Waste Requires an Innovative Solution
Ø Estimated 7.8 billion used syringes annually disposed of outside of the hospital setting (1) requires over 80 million mail-backs per year Ø Tripled since 2001 (1) Ø 13.5 million self-injectors (1) Ø Creates danger for self-injectors, families, and communities $2 Billion Unregulated Market Opportun
Slide 6: Sharps Disposal Legislation for Self-Injectors
States with sharps legislation or regulations in place States with specific guidelines or pending legislation States with no legislation but encourage proper disposal Ø Proposed or enacted legislation covers 43% of the U.S. population (18 states plus D.C.) Sharps Disposal Legislation for Self-Inject
Slide 7: Water Supply Contamination Requires an Innovative Solution
(1) Source: Associated Press Investigative Report Water Supply Contamination… $1 Billion Unregulated Market Opportunity …Requires an Innovative Solution
Slide 8: Unused Medication Disposal Legislation
Legislative Mandates States which introduced legislation States with legislation in place Ø Proposed or enacted legislation covers 65% of the U.S. population (29 states plus D.C.) Unused Medication Disposal Legislation
Slide 9: Rising Costs for Healthcare Providers
(1) Source: Centers for Disease Control and Prevention Rising Costs for Heathcare Providers Ø Healthcare providers looking for ways to reduce costs Ø Decentralization of healthcare delivery $800 Million Regulated Market Opportunity Addressing the Professional Market and the Changing Health Care Deli
Slide 10: Growth Strategy
Growth Strategy Ø Leverage our leadership position Ø Develop innovative solutions to address national challenges Ø Target four key markets to penetrate the $3.8 billion market opportunity
Slide 11: Targeted Market Approach
Direct Sales Telemarketing / Inside Sales E-commerce Distributors Targeted Market Approach
Slide 12: Direct Sales Distributors
Direct Sales Distributors $40 Million Market Opportunity for TakeAway envelopes Sharps Recovery System™ needles and syringes TakeAway Environmental Return System™ unused disposed medication $50 Million Flu Shot Market Opportunity Major Customer Relationships
Slide 13: Direct Sales: Unique Promotional Program
Direct Sales Unique Promotional Program Ø Consumer focused Ø Subsidized by sponsors Ø Pull through drivers: Consumer Behavior - self injector awareness $25 to $40 Million Market Opportunity for Complete Needle™ With 10% to 15% of self-injectors using Complete Needle™
Slide 14: Telemarketing / Inside Sales, E-commerce, Distributors
Telemarketing / Inside Sales E-commerce Distributors Sharps Recovery System™ Ø Support the proper disposal of medical waste generated in physician, dental, veterinarian and other service-related practices Ø Regulated industry: requires proper disposal Ø Estimated 800,000 professional offices across
Slide 15: Direct Sales: Creating Solutions
Direct Sales What they need Ø Product differentiation Ø Improved interaction with patients Ø Touch points with patients Ø Improved therapy outcomes What we offer Ø Launched three new programs from Sept 2011 thru December 2012 Ø Combined value of more than $3 million annually Creating Solutions Ø Our
Slide 16: Direct Sales: U.S. Department of Veterans Affairs
Direct Sales Sharps Recovery System™ & TakeAway Environmental Return System™ U.S. Department of Veterans Affairs Driving New Behaviors Around Medical Waste and Unused Medications Ø Innovative pilot program Ø VA evaluating broad roll-out program to make solutions available across all regions and 5.5
Slide 17: Innovative Solutions
Innovative Solutions… SharpsTracer™ MedTracer™ … for the Professional Market … for the Pharmaceutical Market … for regulatory compliant tracking and proof of receipt and treatment … for the Retail Pharmacy Market See supplemental slides for descriptions of solution offerings
Slide 18: Fully-Integrated Solutions Provider
Fully-Integrated Solutions Provider Vertical Integration: manufacturing assembly distribution treatment online tracking customer reporting regulatory expertise Barriers to Entry Unique solutions Large addressable market
Slide 19: Financial Highlights
Financial Highlights
Slide 20: Growth and Diversity
Growth and Diversity FY 2008 Billings $13.2 million
Slide 21: Building Core Revenue
($ in millions) Building Core Revenue Fiscal Years $39.2 $20.3 Quarterly Trends $4.6 $5.0 $4.5 $5.7 Core Business (recurring revenue markets) U.S. Government Contract $19.4 $21.5 $6.2
Slide 22: Strong Operating Leverage
Gross Margin EBITDA* * See supplemental slides for EBITDA reconciliation and other important disclaimers regarding EBITDA. ($ in millions) Strong Operating Leverage Gross Margin EBITDA* Fiscal Years Quarterly Trends
Slide 23: Investing in Growth
Net Income * Excludes special charge of $512 thousand and an unusual tax benefit of $1.8 million. ** Excludes Q1 FY 2011 special charge of $570 thousand and Q4 FY 2011 unusual expenses of $398 thousand. *** Excludes Q4 FY 2011 unusual expenses of $398 thousand. ($ in millions) Investing in Growth Ne
Slide 24: Strong Balance Sheet: Financial Flexibility
Cash and Cash Equivalents Shareholder Equity Growth 6/30/09 vs. 6/30/11 Line of Credit (As of and for the period ending December 31, 2011) Strong Balance Sheet: Financial Flexibility $18.3M 170% $5.0M No debt as of 12/31/11
Slide 25: Capturing Opportunities - Creating Growth
Capturing Opportunities - Creating Growth Ø $3.8 billion market opportunity Ø First mover advantage Ø Winning major customers in key markets Ø Increasing state and federal regulatory drivers Ø Vertically integrated full-service operations Ø Highly scalable business model with operating leverage Shar
Slide 26: Q & A
Q & A
Slide 27: Supplemental Information
Supplemental Information
Slide 28: EBITDA Reconciliation
Three Months Ended 12/31/2011 9/30/2011 6/30/2011 3/31/2011 12/31/2010 Net Income (loss) $ 28 $ (325) $ (712) $ (659) $ (807) Income tax (benefit) expense 15 (176) (281) (445) (378) Interest (income) expense (10) (10) (13) (14) (15) Depreciation and amortization 278 270 252 252 249 EBITDA $ 311 $ (2
Slide 29: Descriptions
Ø Sharps Recovery System™ (formerly Sharps Disposal by Mail System®) A cost-effective and comprehensive solution for the containment, transportation, treatment and tracking of medical waste and used healthcare materials such as hypodermic needles, lancets, and other used healthcare materials. The so
Slide 30: Descriptions
Descriptions Ø Complete Needle™ Collection & Disposal System A comprehensive solution focused on the traditional under-served home self-injector required to regularly use needles or syringes for their health and well-being, such as people with diabetes. The Complete Needle™ Collection and Disposal S
Slide 31: David P. Tusa, Diana P. Diaz
David P. Tusa Chief Executive Officer and President Diana P. Diaz Vice President and Chief Financial Officer NASDAQ: SMED JANUARY 2012 Investor Presentation
Sharps Compliance — Investor Presentation (January 2012) on 6ix